This guide will walk you through the complexities, ensuring you feel empowered and informed every step of the way
A Changing Landscape: FDA Rescinds Shortage Designation In February 2025, the FDA removed semaglutide from the drug shortage list
But Mounjaro, along with another Lilly drug Trulicity, began facing supply issues last December
Yes, GLP-1 medications and testosterone replacement have no direct contraindication and are frequently used together
In regenerative medicine discussions, BPC-157 peptide therapy is often associated with localized tissue support, particularly in musculoskeletal and connective tissue contexts
Trial dose schedules can change during development, and investigators monitor participants under defined safety rules